Bleeding risks of antithrombotic therapy.
作者信息
Fitzmaurice David A, Blann Andrew D, Lip Gregory Y H
出版信息
BMJ. 2002 Oct 12;325(7368):828-31. doi: 10.1136/bmj.325.7368.828.
Abstract
摘要
相似文献
1
Bleeding risks of antithrombotic therapy.抗血栓治疗的出血风险。
BMJ. 2002 Oct 12;325(7368):828-31. doi: 10.1136/bmj.325.7368.828.
2
Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis.随机对照试验中比较华法林和阿司匹林出血风险的系统评价和荟萃分析。
J Thromb Haemost. 2012 Apr;10(4):512-20. doi: 10.1111/j.1538-7836.2012.04635.x.
3
Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.专业意见：“对于出现急性冠脉综合征和/或接受经皮冠状动脉介入治疗的抗凝患者，推荐使用华法林、阿司匹林和氯吡格雷进行抗栓治疗。”
Thromb Haemost. 2008 Nov;100(5):752-3.
4
Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.反对观点：“对于患有急性冠状动脉综合征和/或接受经皮冠状动脉介入治疗的抗凝患者，推荐使用华法林、阿司匹林和氯吡格雷进行抗栓治疗”。但并非适用于所有人。
Thromb Haemost. 2008 Nov;100(5):754-5.
5
Novel Antithrombotic Drugs on the Horizon: The Ultimate Promise to Prevent Clotting While Avoiding Bleeding.新型抗血栓药物即将问世：预防凝血同时避免出血的终极承诺。
Circ Res. 2017 Oct 27;121(10):1133-1135. doi: 10.1161/CIRCRESAHA.117.312012.
6
[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].[心房颤动的抗栓治疗。新推荐及治疗选择的背景]
Lakartidningen. 2008;105(37):2478-80.
7
Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.经皮冠状动脉介入治疗后三联抗栓治疗的出血并发症
Catheter Cardiovasc Interv. 2017 Feb 1;89(2):E64-E74. doi: 10.1002/ccd.26574. Epub 2016 May 24.
8
9
Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.心房颤动和急性心肌梗死：抗血栓治疗与结局。
Am J Med. 2012 Sep;125(9):897-905. doi: 10.1016/j.amjmed.2012.04.006. Epub 2012 Jul 13.
10
Real risks of two common drugs.两种常见药物的实际风险。
Johns Hopkins Med Lett Health After 50. 1999 May;11(3):3.
引用本文的文献
1
Oral Antithrombotic Medication Is Associated with Improved Visual Outcomes in Eyes with Submacular Hemorrhage from Wet Age-Related Macular Degeneration.口服抗血栓药物与湿性年龄相关性黄斑变性所致黄斑下出血患者的视力改善相关。
Ophthalmol Sci. 2025 Apr 14;5(5):100796. doi: 10.1016/j.xops.2025.100796. eCollection 2025 Sep-Oct.
2
Hematomyelia after epidural anesthesia: a rare complication with putative multifactorial and occult etiology.硬膜外麻醉后脊髓出血：一种罕见的并发症，病因可能是多因素且隐匿的。
Rom J Morphol Embryol. 2025 Jan-Mar;66(1):81-88. doi: 10.47162/RJME.66.1.07.
3
Development of a protease-resistant ADAMTS13 to improve stability against proteolytic degradation.开发一种抗蛋白酶的ADAMTS13以提高其对蛋白水解降解的稳定性。
Blood Adv. 2025 Jun 10;9(11):2695-2705. doi: 10.1182/bloodadvances.2024015212.
4
Safety and Effectiveness of Four-Factor Prothrombin Complex Concentrate in Special Populations with INR Below 2: A Post-Marketing Surveillance Study.四因子凝血酶原复合物浓缩剂在国际标准化比值低于2的特殊人群中的安全性和有效性：一项上市后监测研究
Cardiol Ther. 2024 Sep;13(3):603-614. doi: 10.1007/s40119-024-00380-7. Epub 2024 Aug 3.
5
Antithrombotic management after aortic valve replacement with biological prosthesis: a meta-analysis.生物瓣主动脉瓣置换术后的抗栓治疗：荟萃分析。
J Cardiothorac Surg. 2024 Jun 26;19(1):385. doi: 10.1186/s13019-024-02863-z.
6
Real-World Safety and Effectiveness of a 4-Factor Prothrombin Complex Concentrate in Japanese Patients Experiencing Major Bleeding: A Post-marketing Surveillance Study.四因子凝血酶原复合物浓缩剂在日本大出血患者中的真实世界安全性和有效性：一项上市后监测研究。
Cardiol Ther. 2024 Mar;13(1):221-232. doi: 10.1007/s40119-024-00357-6. Epub 2024 Feb 6.
7
Maxillofacial haemorrhagic symptoms in emergency department patients: impact of antithrombotics.急诊科患者的颌面出血症状：抗栓药物的影响
Eur J Trauma Emerg Surg. 2024 Apr;50(2):543-550. doi: 10.1007/s00068-023-02428-0. Epub 2024 Jan 10.
8
Intraoperative use of fibrin glue in blepharoplasty: a possible solution to reduce postoperative complication.在重睑术中使用纤维蛋白胶：一种减少术后并发症的可能方法。
Sci Rep. 2023 Aug 10;13(1):12982. doi: 10.1038/s41598-023-40183-9.
9
INTERBLEED: Design of an International Study of Risk Factors for Gastrointestinal Bleeding and Cardiovascular Events After Gastrointestinal Bleeding.INTERBLEED：一项关于胃肠道出血及胃肠道出血后心血管事件危险因素的国际研究设计。
CJC Open. 2022 Aug 10;4(11):996-1005. doi: 10.1016/j.cjco.2022.08.002. eCollection 2022 Nov.
10
Hemorrhagic risk prediction in coronary artery disease patients based on photoplethysmography and machine learning.基于光电容积脉搏波和机器学习的冠状动脉疾病患者出血风险预测。
Sci Rep. 2022 Nov 10;12(1):19190. doi: 10.1038/s41598-022-22719-7.
Zotero 插件